首页> 外文期刊>Infectious disorders drug targets >Genetics and Vaccine Development for SARS-CoV2 in the Era of Personalized Medicine
【24h】

Genetics and Vaccine Development for SARS-CoV2 in the Era of Personalized Medicine

机译:Genetics and Vaccine Development for SARS-CoV2 in the Era of Personalized Medicine

获取原文
获取原文并翻译 | 示例
           

摘要

Since the emergence of SARS-CoV-2 in late December 2019, scientists have been racing against time to effectively develop a vaccine. As the techniques of personalized medicine are becoming more understood and approachable for mankind, vaccinations using such technologies could advance the treatment of all patients taking into consideration their genetic and biochemical background. As such, we anticipate that patients will be treated more effectively and potentially have fewer symptoms and side effects. This perspective aims to raise awareness of the oncoming novel treatment of diseases, especially during the coronavirus pandemic.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号